PL3870574T3 - Pochodne aminopirymidyny/pirazyny jako inhibitory CTPS1 - Google Patents
Pochodne aminopirymidyny/pirazyny jako inhibitory CTPS1Info
- Publication number
- PL3870574T3 PL3870574T3 PL19789997.4T PL19789997T PL3870574T3 PL 3870574 T3 PL3870574 T3 PL 3870574T3 PL 19789997 T PL19789997 T PL 19789997T PL 3870574 T3 PL3870574 T3 PL 3870574T3
- Authority
- PL
- Poland
- Prior art keywords
- aminopyrimidine
- pyrazine derivatives
- ctps1 inhibitors
- ctps1
- inhibitors
- Prior art date
Links
- 102100039866 CTP synthase 1 Human genes 0.000 title 1
- 101001101919 Homo sapiens CTP synthase 1 Proteins 0.000 title 1
- 150000005005 aminopyrimidines Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000003216 pyrazines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18202136 | 2018-10-23 | ||
| PCT/EP2018/086617 WO2019179652A1 (en) | 2018-03-23 | 2018-12-21 | Aminopyrimidine derivatives as ctps1 inhibitors |
| PCT/EP2019/057320 WO2019180244A1 (en) | 2018-03-23 | 2019-03-22 | Aminopyrimidine derivatives as ctps1 inhibitors |
| PCT/EP2019/078848 WO2020083975A1 (en) | 2018-10-23 | 2019-10-23 | Aminopyrimidine/pyrazine derivatives as ctps1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3870574T3 true PL3870574T3 (pl) | 2023-05-02 |
Family
ID=63965420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19789997.4T PL3870574T3 (pl) | 2018-10-23 | 2019-10-23 | Pochodne aminopirymidyny/pirazyny jako inhibitory CTPS1 |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US11987573B2 (pl) |
| EP (1) | EP3870574B1 (pl) |
| JP (1) | JP7308263B2 (pl) |
| CN (1) | CN112839938B (pl) |
| AU (1) | AU2019367191B2 (pl) |
| BR (1) | BR112021005986A2 (pl) |
| CA (1) | CA3115568C (pl) |
| CR (1) | CR20210265A (pl) |
| DK (1) | DK3870574T3 (pl) |
| EA (1) | EA202191104A1 (pl) |
| ES (1) | ES2941981T3 (pl) |
| FI (1) | FI3870574T3 (pl) |
| HR (1) | HRP20230328T1 (pl) |
| HU (1) | HUE061652T2 (pl) |
| IL (1) | IL282386B2 (pl) |
| LT (1) | LT3870574T (pl) |
| MX (1) | MX2021004659A (pl) |
| MY (1) | MY203303A (pl) |
| NZ (1) | NZ774355A (pl) |
| PL (1) | PL3870574T3 (pl) |
| PT (1) | PT3870574T (pl) |
| RS (1) | RS64081B1 (pl) |
| SG (1) | SG11202103823PA (pl) |
| SI (1) | SI3870574T1 (pl) |
| SM (1) | SMT202300090T1 (pl) |
| WO (1) | WO2020083975A1 (pl) |
| ZA (1) | ZA202101788B (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019106146A1 (en) | 2017-11-30 | 2019-06-06 | Step Pharma S.A.S. | Compounds |
| EP3717459B1 (en) | 2017-11-30 | 2026-01-21 | Step Pharma S.A.S. | Compounds |
| EP3980410B1 (en) | 2019-06-04 | 2025-02-19 | Step Pharma S.A.S. | N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl)butanamide derivatives and related compounds as human ctps1 inhibitors for the treatment of proliferative diseases |
| ES3044436T3 (en) | 2019-06-04 | 2025-11-26 | Step Pharma S A S | N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(ethylsulfonamido)pyrimidin-4-yl)tetrahydro-2h-pyran-4-carboxamide as a human ctps1 inhibitor for the treatment of proliferative diseases |
| WO2021053402A2 (en) | 2019-09-20 | 2021-03-25 | Step Pharma S.A.S. | Compounds |
| EP4041715A1 (en) | 2019-09-20 | 2022-08-17 | Step Pharma S.A.S. | Sulfonamide inhibitors as ctps 1 inhibitors |
| WO2023166077A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | Combination of a ctps1 inhibitor and a atr inhibitor in cancer therapy |
| WO2023166080A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | Combination treatments comprising a ctps1 inhibitor and a wee1 inhibitor |
| EP4486347A1 (en) | 2022-03-01 | 2025-01-08 | Step Pharma S.A.S. | Combinations of ctps1 and bcl2 inhibitors for cancer |
| WO2023166078A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | Combination treatments comprising a ctps1 inhibitor and a chek1 inhibitor |
| CN120359033A (zh) | 2022-12-21 | 2025-07-22 | 斯泰普制药股份公司 | 用于治疗ctps2缺乏型癌症的ctps1抑制剂 |
| WO2024133721A1 (en) | 2022-12-21 | 2024-06-27 | Step Pharma S.A.S. | Combinations of ctps1 inhibitor with iap inhibitor for use in the treatment of cancer |
| CN118359588A (zh) * | 2023-01-19 | 2024-07-19 | 杭州英创医药科技有限公司 | 作为ctps1抑制剂的化合物 |
| WO2026027753A1 (en) * | 2024-08-02 | 2026-02-05 | Step Pharma S.A.S. | Ctps1 inhibitors for the treatment of myeloproliferative neoplasms |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1575803A (en) | 1976-03-09 | 1980-10-01 | Fujisawa Pharmaceutical Co | 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof |
| GB1555007A (en) | 1976-05-25 | 1979-11-07 | Fujisawa Pharmaceutical Co | Intermediates in the preparation of substituted cepham carboxylic acid derivatives and the preparation thereof |
| AU2001280229B2 (en) | 2000-08-21 | 2006-12-07 | Pacific Corporation | Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| JP2004509874A (ja) | 2000-09-25 | 2004-04-02 | アクテリオン ファマシューティカルズ リミテッド | 新規なアリールアルカン−スルフォンアミド類 |
| US20030158218A1 (en) | 2001-12-21 | 2003-08-21 | Nantermet Philippe G. | Thrombin inhibitors |
| CA2570903C (en) | 2004-07-26 | 2013-09-17 | Applied Research Systems Ars Holding N.V. | N-hydroxyamide derivatives and use thereof |
| EP1659113A1 (en) * | 2004-11-08 | 2006-05-24 | Evotec AG | Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1) |
| AR063706A1 (es) | 2006-09-11 | 2009-02-11 | Cgi Pharmaceuticals Inc | Determinadas amidas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmaceuticas que las comprenden. |
| AU2008335709A1 (en) | 2007-12-13 | 2009-06-18 | Amgen Inc. | Gamma secretase modulators |
| KR101097312B1 (ko) | 2009-08-10 | 2011-12-23 | 삼성모바일디스플레이주식회사 | 유기 발광 소자 |
| CN104837837B (zh) | 2012-12-13 | 2017-04-05 | 弗·哈夫曼-拉罗切有限公司 | 作为布鲁顿氏酪氨酸激酶抑制剂的噻唑衍生物 |
| JP2016028795A (ja) | 2013-03-28 | 2016-03-03 | 国立研究開発法人科学技術振興機構 | 触媒金属ナノ粒子含有複合体及びその利用 |
| CN105473136A (zh) * | 2013-04-18 | 2016-04-06 | 国家健康与医学研究院 | 用于在有此需要的受试者中抑制淋巴细胞增殖的方法和药物组合物 |
| WO2014186435A2 (en) | 2013-05-14 | 2014-11-20 | University Of Georgia Research Foundation, Inc. | Compositions and methods for reducing neointima formation |
| GB201322333D0 (en) | 2013-12-17 | 2014-01-29 | Agency Science Tech & Res | WNT pathway modulators |
| CN104262071A (zh) | 2014-10-16 | 2015-01-07 | 中国科学院山西煤炭化学研究所 | 一种联苯类化合物的光催化合成方法 |
| EP3717459B1 (en) | 2017-11-30 | 2026-01-21 | Step Pharma S.A.S. | Compounds |
| WO2019106146A1 (en) | 2017-11-30 | 2019-06-06 | Step Pharma S.A.S. | Compounds |
| WO2019180244A1 (en) | 2018-03-23 | 2019-09-26 | Step Pharma S.A.S. | Aminopyrimidine derivatives as ctps1 inhibitors |
| WO2019179652A1 (en) | 2018-03-23 | 2019-09-26 | Step Pharma S.A.S. | Aminopyrimidine derivatives as ctps1 inhibitors |
| US20230192673A1 (en) * | 2018-06-04 | 2023-06-22 | Step Pharma S.A.S. | Compounds |
| US12331046B2 (en) | 2020-10-23 | 2025-06-17 | Nimbus Clotho, Inc. | CTPS1 inhibitors and uses thereof |
-
2019
- 2019-10-23 LT LTEPPCT/EP2019/078848T patent/LT3870574T/lt unknown
- 2019-10-23 SG SG11202103823PA patent/SG11202103823PA/en unknown
- 2019-10-23 HR HRP20230328TT patent/HRP20230328T1/hr unknown
- 2019-10-23 ES ES19789997T patent/ES2941981T3/es active Active
- 2019-10-23 MY MYPI2021002215A patent/MY203303A/en unknown
- 2019-10-23 HU HUE19789997A patent/HUE061652T2/hu unknown
- 2019-10-23 CA CA3115568A patent/CA3115568C/en active Active
- 2019-10-23 AU AU2019367191A patent/AU2019367191B2/en active Active
- 2019-10-23 MX MX2021004659A patent/MX2021004659A/es unknown
- 2019-10-23 IL IL282386A patent/IL282386B2/en unknown
- 2019-10-23 JP JP2021522085A patent/JP7308263B2/ja active Active
- 2019-10-23 EA EA202191104A patent/EA202191104A1/ru unknown
- 2019-10-23 WO PCT/EP2019/078848 patent/WO2020083975A1/en not_active Ceased
- 2019-10-23 NZ NZ774355A patent/NZ774355A/en unknown
- 2019-10-23 EP EP19789997.4A patent/EP3870574B1/en active Active
- 2019-10-23 DK DK19789997.4T patent/DK3870574T3/da active
- 2019-10-23 US US17/287,137 patent/US11987573B2/en active Active
- 2019-10-23 PT PT197899974T patent/PT3870574T/pt unknown
- 2019-10-23 SI SI201930504T patent/SI3870574T1/sl unknown
- 2019-10-23 BR BR112021005986-5A patent/BR112021005986A2/pt active Search and Examination
- 2019-10-23 FI FIEP19789997.4T patent/FI3870574T3/fi active
- 2019-10-23 PL PL19789997.4T patent/PL3870574T3/pl unknown
- 2019-10-23 RS RS20230239A patent/RS64081B1/sr unknown
- 2019-10-23 CR CR20210265A patent/CR20210265A/es unknown
- 2019-10-23 SM SM20230090T patent/SMT202300090T1/it unknown
- 2019-10-23 CN CN201980063914.3A patent/CN112839938B/zh active Active
-
2021
- 2021-03-17 ZA ZA2021/01788A patent/ZA202101788B/en unknown
-
2024
- 2024-04-16 US US18/636,731 patent/US12371419B2/en active Active
-
2025
- 2025-05-23 US US19/217,739 patent/US20250282756A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3870574T3 (pl) | Pochodne aminopirymidyny/pirazyny jako inhibitory CTPS1 | |
| LT3768674T (lt) | Aminopirimidino dariniai kaip ctps1 inhibitoriai | |
| DK3784664T3 (da) | 2-amino-pyridin- eller 2-amino-pyrimidinderivater som cyclinafhængige kinasehæmmere | |
| IL280593A (en) | Pyrrolopyrimidine itk inhibitors | |
| PL3697785T3 (pl) | Związki imidazopirydynowe jako inhibitory pad | |
| DK3788040T3 (da) | Pyridazinoner som parp7-inhibitorer | |
| DK3324977T3 (da) | Benzodiazepinderivater som rsv-inhibitorer | |
| PL3209656T3 (pl) | Związki indolo-karboksyamidu użyteczne jako inhibitory kinazy | |
| PL3442535T3 (pl) | Związki heterocykliczne jako inhibitory kinazy ret | |
| PL3224256T3 (pl) | Związki n-((het)arylometylo-heteroarylo-karboksyamidowe jako inhibitory kalikreiny osoczowej | |
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| PL3468966T3 (pl) | Inhibitory interakcji menina-mll | |
| PL3539961T3 (pl) | Policykliczne pochodne amidowe jako inhibitory CDK9 | |
| PL3672965T3 (pl) | Związek pirymidynowy jako inhibitor kinazy JAK | |
| DK3433253T3 (da) | Pyrimidinforbindelse som JAK-kinase-inhibitorer | |
| IL265166B (en) | Anti-influenza virus pyrimidine derivatives | |
| DK3592745T3 (da) | Pyrimidopyrimidinoner anvendelige som Wee-1 kinaseinhibitorer | |
| PL4010330T3 (pl) | Pochodne chinoliny jako inhibitory kinazy białkowej | |
| EP3564216A4 (en) | PYRIMIDINE DERIVATIVE | |
| PL3833665T3 (pl) | Diazabicykloktanony jako inhibitory beta-laktamaz serynowych | |
| EP3884940A4 (en) | Novel imidazole derivative | |
| EP3615525C0 (en) | PYRROLE DERIVATIVES AS PLK1 INHIBITORS | |
| DK3890828T3 (da) | Heteroaromatiske forbindelser som vanin-hæmmere | |
| PL3894410T3 (pl) | Podstawione pochodne ksantyny | |
| DK3790873T3 (da) | 1h-indazol-3-carboxamidforbindelser som glycogensynthase-kinase-3-beta-inhibitorer |